Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease-Reference-Cited by-同舟云学术

Frequent health care utilisation and avascular necrosis are associated with cannabis use in adults with sickle cell disease

Published:2021-10-18 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Miodownik Hope¹,Curtis Susanna A.²,Olivia Ogu Ugochi²³^ORCID,Bradford Christopher¹,Starrels Joanna L.⁴,Cunningham Chinazo O.⁴,Arnsten Julia H.⁴,Choi Jaeun⁵,Eisenberg Ruth⁵,Minniti Caterina P.¹²^ORCID

Affiliation:

1. Albert Einstein College of Medicine Bronx NYUSA

2. Division of Hematology Montefiore Health Systems Albert Einstein College of Medicine Bronx NYUSA

3. Center for Sickle Cell Disease University of Tennessee Health Science Center Memphis TNUSA

4. Division of General Internal Medicine Montefiore Medical Center Albert Einstein College of MedicineBronx NYUSA

5. Department of Epidemiology and Population Health Albert Einstein College of Medicine Bronx NY USA

Funder

National Institute on Drug Abuse

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17901

Reference11 articles.

1. Marijuana Use in Adults Living with Sickle Cell Disease

2. The prevalence of marijuana smoking in young adults with sickle cell disease: a longitudinal study

3. Cannabis use in sickle cell disease: a questionnaire study

4. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease

5. Daily Cannabis Users with Sickle Cell Disease Show Fewer Admissions than Others with Similar Pain Complaints

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploratory survey study on adjunctive use of medical cannabis for Gaucher disease;Rare Disease and Orphan Drugs Journal;2024-08-23

2. Risks and benefits of cannabis as a pain control modality in patients with sickle cell disease;Clinical Hematology International;2023-12-18